AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. KOBAYASHI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Gross margin (%)

KOBAYASHI PHARMACEUTICAL CO.,LTD.【JP:4967】

Market cap
¥437.1B
P/E ratio
41.6x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndGross margin (%) YoY (%)
Dec 31, 202551.1-3.38%
Dec 31, 202452.9-4.79%
Dec 31, 202355.6+0.05%
Dec 31, 202255.5-2.88%
Dec 31, 202157.2+0.94%
Dec 31, 202056.6-7.88%
Dec 31, 201961.5-0.12%
Dec 31, 201861.6+1.04%
Dec 31, 201760.9+2.44%
Dec 31, 201659.5+2.42%
Mar 31, 201658.1+1.25%
Mar 31, 201557.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)